Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

被引：0
|
作者：
Nathan J. Lanning
Joshua P. Castle
Simar J. Singh
Andre N. Leon
Elizabeth A. Tovar
Amandeep Sanghera
Jeffrey P. MacKeigan
Fabian V. Filipp
Carrie R. Graveel
机构：
[1] California State University,Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology
[2] Van Andel Research Institute,College of Human Medicine
[3] University of California Merced,undefined
[4] Michigan State University,undefined
来源：
Cancer & Metabolism | / 5卷
关键词：
Triple-negative breast cancer; Metabolism; Rate-limiting enzymes; Receptor tyrosine kinase; Tyrosine kinase inhibitor; Metabolic inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Targeting metabolic vulnerabilities to reduce triple negative breast cancer health disparities
    Marquez-Garban, Diana C.
    Deng, Gang
    Burton, Lorena P.
    Ma, Gaoyuan
    Muhunthan, Vishaka
    Comin-Anduix, Begonya
    Llarena, Gabriela
    Moatamed, Neda
    Murphy, Jennifer
    Hamilton, Nalo
    Shackelford, Daivd
    Jung, Michael E.
    Pietras, Richard J.
    CANCER RESEARCH, 2023, 83 (07)
  • [22] Key Players in Choline Metabolic Reprograming in Triple-negative Breast Cancer
    Iorio, Egidio
    Caramujo, Maria Jose
    Cecchetti, Serena
    Spadaro, Francesca
    Carpinelli, Giulia
    Canese, Rossella
    Podo, Franca
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [23] Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
    Munkacsy, Gyongyi
    Santarpia, Libero
    Gyorffy, Balazs
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [24] The role of metabolic reprogramming in immune escape of triple-negative breast cancer
    Bao, Ruochen
    Qu, Hongtao
    Li, Baifeng
    Cheng, Kai
    Miao, Yandong
    Wang, Jiangtao
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [25] Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets
    Gong, Yue
    Ji, Peng
    Yang, Yun-Song
    Xie, Shao
    Yu, Tian-Jian
    Xiao, Yi
    Jin, Ming-Liang
    Ma, Ding
    Guo, Lin-Wei
    Pei, Yu-Chen
    Chai, Wen-Jun
    Li, Da-Qiang
    Bai, Fan
    Bertucci, Francois
    Hu, Xin
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    CELL METABOLISM, 2021, 33 (01) : 51 - +
  • [26] Genomic Profiling in Triple-Negative Breast Cancer
    Liedtke, Cornelia
    Bernemann, Christof
    Kiesel, Ludwig
    Rody, Achim
    BREAST CARE, 2013, 8 (06) : 408 - 413
  • [27] Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast Cancer
    Liu, Yi-Rong
    Jiang, Yi-Zhou
    Xu, Xiao-En
    Hu, Xin
    Yu, Ke-Da
    Shao, Zhi-Ming
    CLINICAL CANCER RESEARCH, 2016, 22 (07) : 1653 - 1662
  • [28] Metabolomics Analysis Reveals Altered Metabolic Pathways and Response to Doxorubicin in Drug-Resistant Triple-Negative Breast Cancer Cells
    Rushing, Blake R.
    Molina, Sabrina
    Sumner, Susan
    METABOLITES, 2023, 13 (07)
  • [29] Unveiling the vulnerabilities of synthetic lethality in triple-negative breast cancer
    Prarthana Chatterjee
    Rohit Karn
    Arnold Emerson Isaac
    Smita Ray
    Clinical and Translational Oncology, 2023, 25 : 3057 - 3072
  • [30] Unveiling the vulnerabilities of synthetic lethality in triple-negative breast cancer
    Chatterjee, Prarthana
    Karn, Rohit
    Isaac, Arnold Emerson
    Ray, Smita
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (11): : 3057 - 3072
12345